Debbie Johnston, Senior Vice President of Policy Development
Earlier this week, the Food and Drug Administration (FDA) awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures. The FDA's announcement comes on the heels of a recent release by the Agency for Healthcare Research and Quality (AHRQ) of an online toolkit to help primary care practices improve care for patients taking opioids for chronic pain.
AzHHA is very hopeful these national tools will augment the hard work that providers, community partners and state agencies are doing locally to address the opioid epidemic. As Congress moves closer to passing federal legislation to address the epidemic, it is even more imperative that our state and national efforts align.